195 related articles for article (PubMed ID: 35931197)
21. G-protein-independent coupling of MC4R to Kir7.1 in hypothalamic neurons.
Ghamari-Langroudi M; Digby GJ; Sebag JA; Millhauser GL; Palomino R; Matthews R; Gillyard T; Panaro BL; Tough IR; Cox HM; Denton JS; Cone RD
Nature; 2015 Apr; 520(7545):94-8. PubMed ID: 25600267
[TBL] [Abstract][Full Text] [Related]
22. Structural insight into the MC4R conformational changes via different agonist-mediated receptor signaling.
Yang Y; Chen M; Dimmitt R; Harmon CM
Biochemistry; 2014 Nov; 53(45):7086-92. PubMed ID: 25347793
[TBL] [Abstract][Full Text] [Related]
23. Setmelanotide: First Approval.
Markham A
Drugs; 2021 Feb; 81(3):397-403. PubMed ID: 33638809
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist.
Xiang Z; Proneth B; Dirain ML; Litherland SA; Haskell-Luevano C
Biochemistry; 2010 Jun; 49(22):4583-600. PubMed ID: 20462274
[TBL] [Abstract][Full Text] [Related]
25. Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor.
Kleinau G; Heyder NA; Tao YX; Scheerer P
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785054
[TBL] [Abstract][Full Text] [Related]
26. Setmelanotide optimization through fragment-growing, molecular docking in-silico method targeting MC4 receptor.
Jia X; Fan S; Dong W; Li S; Zhang Y; Ma Y; Wang S
J Biomol Struct Dyn; 2023; 41(24):15411-15420. PubMed ID: 37126536
[TBL] [Abstract][Full Text] [Related]
27. Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists.
Molden BM; Cooney KA; West K; Van Der Ploeg LH; Baldini G
Mol Endocrinol; 2015 Nov; 29(11):1619-33. PubMed ID: 26418335
[TBL] [Abstract][Full Text] [Related]
28. Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors.
Mo XL; Tao YX
Biochim Biophys Acta; 2013 Dec; 1832(12):1939-48. PubMed ID: 23791567
[TBL] [Abstract][Full Text] [Related]
29. A Melanocortin-4 Receptor Agonist Induces Skin and Hair Pigmentation in Patients with Monogenic Mutations in the Leptin-Melanocortin Pathway.
Kanti V; Puder L; Jahnke I; Krabusch PM; Kottner J; Vogt A; Richter C; Andruck A; Lechner L; Poitou C; Krude H; Gottesdiener K; Clément K; Farooqi IS; Wiegand S; Kühnen P; Blume-Peytavi U
Skin Pharmacol Physiol; 2021; 34(6):307-316. PubMed ID: 34058738
[TBL] [Abstract][Full Text] [Related]
30. Immunoglobulin G modulation of the melanocortin 4 receptor signaling in obesity and eating disorders.
Lucas N; Legrand R; Bôle-Feysot C; Breton J; Coëffier M; Akkermann K; Järv A; Harro J; Déchelotte P; Fetissov SO
Transl Psychiatry; 2019 Feb; 9(1):87. PubMed ID: 30755592
[TBL] [Abstract][Full Text] [Related]
31. Functional Characterization of Novel
Mohammed I; Selvaraj S; Ahmed WS; Al-Barazenji T; Hammad AS; Dauleh H; Saraiva LR; Al-Shafai M; Hussain K
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003551
[TBL] [Abstract][Full Text] [Related]
32. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.
Fleck BA; Ling N; Chen C
Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970
[TBL] [Abstract][Full Text] [Related]
33. Key amino acid residue in Melanocortin-1 receptor (melanocyte α-MSH receptor) for ligand selectivity.
Yang Y; Chen M; Ventro G; Harmon CM
Mol Cell Endocrinol; 2017 Oct; 454():69-76. PubMed ID: 28579117
[TBL] [Abstract][Full Text] [Related]
34. Exposure of MC4R to agonist in the endoplasmic reticulum stabilizes an active conformation of the receptor that does not desensitize.
Granell S; Molden BM; Baldini G
Proc Natl Acad Sci U S A; 2013 Dec; 110(49):E4733-42. PubMed ID: 24248383
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice.
Kumar KG; Sutton GM; Dong JZ; Roubert P; Plas P; Halem HA; Culler MD; Yang H; Dixit VD; Butler AA
Peptides; 2009 Oct; 30(10):1892-900. PubMed ID: 19646498
[TBL] [Abstract][Full Text] [Related]
36. A Gut-Intrinsic Melanocortin Signaling Complex Augments L-Cell Secretion in Humans.
Sun EW; Iepsen EW; Pezos N; Lumsden AL; Martin AM; Schober G; Isaacs NJ; Rayner CK; Nguyen NQ; de Fontgalland D; Rabbitt P; Hollington P; Wattchow DA; Hansen T; Holm JC; Liou AP; Jackson VM; Torekov SS; Young RL; Keating DJ
Gastroenterology; 2021 Aug; 161(2):536-547.e2. PubMed ID: 33848536
[TBL] [Abstract][Full Text] [Related]
37. Melanocortin-4 receptor complexity in energy homeostasis,obesity and drug development strategies.
Fatima MT; Ahmed I; Fakhro KA; Akil ASA
Diabetes Obes Metab; 2022 Apr; 24(4):583-598. PubMed ID: 34882941
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological chaperone action in humanized mouse models of MC4R-linked obesity.
René P; Lanfray D; Richard D; Bouvier M
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33434184
[TBL] [Abstract][Full Text] [Related]
39. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.
Marsh DJ; Hollopeter G; Huszar D; Laufer R; Yagaloff KA; Fisher SL; Burn P; Palmiter RD
Nat Genet; 1999 Jan; 21(1):119-22. PubMed ID: 9916804
[TBL] [Abstract][Full Text] [Related]
40. Molecular cloning, tissue distribution, and pharmacological characterization of melanocortin-4 receptor in grass carp (Ctenopharyngodon idella).
Li L; Yang Z; Zhang YP; He S; Liang XF; Tao YX
Domest Anim Endocrinol; 2017 Apr; 59():140-151. PubMed ID: 28152402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
